🔎 Trials Near Me

Pradžia › Priepuoliai › Mičiganas

Priepuoliai klinikiniai tyrimai Mičiganas

7 tyrimai dėl Priepuoliai ieško dalyvių vietose Mičiganas.

Miestai Mičiganas

Oficialus tyrimo tekstas (anglų kalba)

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

  • Wayne State University, Detroit
  • Corewell Health, Grand Rapids
Renkami dalyviai1 fazė
Amžius nuo 12 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07233239

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  • Wayne State University - Detroit Medical Center, Detroit
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06798896

Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

  • C.S. Mott Children's Hospital, Ann Arbor
Renkami dalyviaiStebimasis tyrimas
Iki 26 metų · Visoms lytims · Atnaujinta 2026-08-06 · NCT05374824

Outcomes After Planned Discontinuation of AntiSeizure Medication

  • University of Michigan, Ann Arbor
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT07750496

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • Wayne State University/Detroit Medical Center Comprehensive Epilepsy Program, Detroit
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-06-09 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • 9D University Health Center, Detroit
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-14 · NCT05716100

Pediatric Dose Optimization for Seizures in Emergency Medical Services

  • University of Michigan, Ann Arbor
Renkami dalyviai3 fazė
6 Months – 13 Years · Visoms lytims · Atnaujinta 2025-09-30 · NCT05121324

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.